879169 - Incyte Corp - SEC Form 4 Insider Trading Screener

Services - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research - INCY (879169)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P3+1-5-13+0
S13-0-4-7+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-11-01
INCYGryska David WEVP, CFOF - Tax$107.96-3,91313,992-22%-$422,447
2017-11-02
INCYGryska David WEVP, CFOS - Sale$105.63-3,91513,992-22%-$413,541
2017-09-29
INCYBaker Bros. Advisors LPDir, 10%A - Grant$116.74+486942,6690%+$56,736
2017-09-29
INCYDixon Wendy LDirA - Grant$116.74+1399,101+2%+$16,227
2017-09-29
INCYBrooke Paul ADirA - Grant$116.74+203197,3240%+$23,698
2017-09-29
INCYBienaime Jean JacquesDirA - Grant$116.74+1244,916+3%+$14,476
2017-09-18
INCYHoppenot HerveCOB , CEOS - Sale$119.45-70,502299,004-19%-$8,421,464
2017-09-13
INCYWenqing YaoEVP, Head of Discovery ChemF - Tax$123.15-67436,610-2%-$83,003
2017-09-13
INCYSwain Paula JEVP, HRF - Tax$123.15-67434,393-2%-$83,003
2017-09-13
INCYStein Steven HEVP, Chief Medical OfficerF - Tax$123.15-62517,540-3%-$76,969
2017-09-13
INCYSiegel Eric H.EVP, GCF - Tax$123.15-68021,053-3%-$83,742
2017-09-13
INCYHuber Reid MEVP, Chief Scientific OfficerF - Tax$123.15-69238,862-2%-$85,220
2017-09-13
INCYHoppenot HerveCOB , CEOF - Tax$123.15-2,486369,506-1%-$306,151
2017-09-13
INCYGryska David WEVP, CFOF - Tax$123.15-71221,820-3%-$87,683
2017-09-13
INCYFlannelly Barry PEVP, GM USF - Tax$123.15-67414,782-4%-$83,003
2017-09-14
INCYFlannelly Barry PEVP, GM USS - Sale$124.25-71414,782-5%-$88,715
2017-09-08
INCYBaker Bros. Advisors LPDir, 10%P - Purchase$132.00+100,000942,507+12%+$13,200,000
D
2017-09-05
INCYTrower PaulPrincipal Accounting OfficerM - OptEx$17.79+3,00026,706+13%+$53,370
D
2017-09-05
INCYTrower PaulPrincipal Accounting OfficerS - Sale+OE$138.41-3,00026,706-10%-$415,230
D
2017-09-01
INCYSiegel Eric H.EVP, GCM - OptEx$64.55+1,82021,733+9%+$117,481
D
2017-09-01
INCYSiegel Eric H.EVP, GCS - Sale+OE$137.40-1,82021,733-8%-$250,068
D
2017-08-31
INCYSwain Paula JEVP, HRM - OptEx$17.79+20,00035,067+133%+$355,800
D
2017-08-31
INCYSwain Paula JEVP, HRS - Sale+OE$140.00-20,00035,067-36%-$2,800,000
D
2017-08-29
INCYStein Steven HEVP, Chief Medical OfficerM - OptEx$89.52+2,11118,165+13%+$188,974
D
2017-08-29
INCYStein Steven HEVP, Chief Medical OfficerS - Sale+OE$125.00-2,11118,165-10%-$263,875
D
2017-08-03
INCYTrower PaulPrincipal Accounting OfficerF - Tax$125.98-29526,706-1%-$37,164
D
2017-08-04
INCYTrower PaulPrincipal Accounting OfficerM - OptEx$17.79+3,00026,706+13%+$53,370
D
2017-08-04
INCYTrower PaulPrincipal Accounting OfficerS - Sale+OE$125.25-3,00026,706-10%-$375,750
D
2017-08-01
INCYSiegel Eric H.EVP, GCM - OptEx$64.55+1,82021,733+9%+$117,481
D
2017-08-01
INCYSiegel Eric H.EVP, GCS - Sale+OE$132.92-1,82021,733-8%-$241,914
D
2017-07-20
INCYStein Steven HEVP, Chief Medical OfficerM - OptEx$85.68+6,48518,165+56%+$555,641
D
2017-07-20
INCYStein Steven HEVP, Chief Medical OfficerS - Sale+OE$131.09-6,48518,165-26%-$850,119
D
2017-07-05
INCYFlannelly Barry PEVP, GM USA - Grant$0.00+3,51716,170+28%+$0
D
2017-07-05
INCYTrower PaulPrincipal Accounting OfficerA - Grant$0.00+1,19812,148+11%+$0
D
2017-07-05
INCYTrower PaulPrincipal Accounting OfficerM - OptEx$17.79+3,00012,148+33%+$53,370
D
2017-07-05
INCYTrower PaulPrincipal Accounting OfficerS - Sale+OE$126.18-3,00012,148-20%-$378,540
D
2017-07-05
INCYHoppenot HerveCOB , CEOA - Grant$0.00+13,679371,992+4%+$0
D
2017-07-05
INCYGryska David WEVP, CFOA - Grant$0.00+3,51722,532+18%+$0
D
2017-07-05
INCYWenqing YaoEVP, Head of Discovery ChemA - Grant$0.00+3,51737,284+10%+$0
D
2017-07-05
INCYIyengar Vijay KEVP GPS, BD, LicensingA - Grant$0.00+3,5178,510+70%+$0
D
2017-07-05
INCYSiegel Eric H.EVP, GCA - Grant$0.00+3,51721,733+19%+$0
D
2017-07-05
INCYHuber Reid MEVP, Chief Scientific OfficerA - Grant$0.00+3,51739,554+10%+$0
D
2017-07-05
INCYSwain Paula JEVP, HRA - Grant$0.00+3,51735,067+11%+$0
D
2017-07-05
INCYStein Steven HEVP, Chief Medical OfficerA - Grant$0.00+3,51718,165+24%+$0
D
2017-07-03
INCYSiegel Eric H.EVP, GCM - OptEx$64.55+1,82018,216+11%+$117,481
D
2017-07-03
INCYSiegel Eric H.EVP, GCS - Sale+OE$126.20-1,82018,216-9%-$229,684
2017-06-30
INCYDixon Wendy LDirA - Grant$125.91+1298,962+1%+$16,242
2017-06-30
INCYBrooke Paul ADirA - Grant$125.91+188197,1210%+$23,671
2017-06-30
INCYBienaime Jean JacquesDirA - Grant$125.91+1154,792+2%+$14,480
D
2017-06-30
INCYGryska David WEVP, CFOM - OptEx$73.21+59919,015+3%+$43,853
D
2017-06-30
INCYGryska David WEVP, CFOS - Sale+OE$129.74-59919,015-3%-$77,714
D
2017-06-20
INCYStein Steven HEVP, Chief Medical OfficerM - OptEx$91.45+9,88314,648+207%+$903,824
D
2017-06-20
INCYStein Steven HEVP, Chief Medical OfficerS - Sale+OE$125.00-9,88314,648-40%-$1,235,375
D
2017-06-12
INCYGryska David WEVP, CFOM - OptEx$73.21+16,75619,015+742%+$1,226,707
D
2017-06-12
INCYGryska David WEVP, CFOS - Sale+OE$116.60-16,75619,015-47%-$1,953,750
D
2017-06-06
INCYSiegel Eric H.EVP, GCM - OptEx$66.66+1,29218,216+8%+$86,127
D
2017-06-05
INCYTrower PaulPrincipal Accounting OfficerM - OptEx$17.79+3,00010,950+38%+$53,370
D
2017-06-05
INCYTrower PaulPrincipal Accounting OfficerS - Sale+OE$132.50-3,00010,950-22%-$397,500
D
2017-06-01
INCYSiegel Eric H.EVP, GCM - OptEx$64.55+1,82016,924+12%+$117,481
D
2017-06-01
INCYSiegel Eric H.EVP, GCS - Sale+OE$130.00-1,82016,924-10%-$236,600
2017-05-31
INCYBienaime Jean JacquesDirP - Purchase$131.80+5004,677+12%+$65,900
2017-05-15
INCYBienaime Jean JacquesDirP - Purchase$115.00+5004,177+14%+$57,500
2017-05-05
INCYHuber Reid MEVP, Chief Scientific OfficerF - Tax$125.00-7,73236,037-18%-$966,500-1
2017-05-08
INCYHuber Reid MEVP, Chief Scientific OfficerS - Sale$119.21-8,57736,037-19%-$1,022,464-1
2017-05-05
INCYWenqing YaoEVP, Head of Discovery ChemF - Tax$125.00-4,41333,767-12%-$551,625-1
D
2017-05-05
INCYTrower PaulPrincipal Accounting OfficerM - OptEx$17.79+3,00010,950+38%+$53,370-1
D
2017-05-05
INCYTrower PaulPrincipal Accounting OfficerS - Sale+OE$121.70-3,00010,950-22%-$365,100-1
D
2017-05-01
INCYFlannelly Barry PEVP, GM USM - OptEx$48.44+2,06412,653+19%+$99,9800-5
D
2017-05-01
INCYFlannelly Barry PEVP, GM USS - Sale+OE$124.73-5,29612,653-30%-$660,5640-5
D
2017-05-01
INCYSiegel Eric H.EVP, GCM - OptEx$64.55+1,82016,924+12%+$117,4810-5
D
2017-05-01
INCYSiegel Eric H.EVP, GCS - Sale+OE$124.73-1,82016,924-10%-$227,0090-5
D
2017-04-28
INCYGryska David WEVP, CFOM - OptEx$67.06+1,38919,015+8%+$93,1460-5
D
2017-04-28
INCYGryska David WEVP, CFOS - Sale+OE$124.26-1,38919,015-7%-$172,5970-5
2017-04-28
INCYBienaime Jean JacquesDirP - Purchase$124.26+5003,677+16%+$62,1300-5
D
2017-04-27
INCYBaker Bros. Advisors LPDir, 10%M - OptEx$7.26+60,000940,328+7%+$435,6000+1
2017-04-13
INCYBienaime Jean JacquesDirP - Purchase$139.66+1,0003,177+46%+$139,6600-2
D
2017-04-07
INCYStein Steven HEVP, Chief Medical OfficerM - OptEx$89.79+32,00014,648-184%+$2,873,160+2-7-13
D
2017-04-07
INCYStein Steven HEVP, Chief Medical OfficerS - Sale+OE$137.88-32,00014,648-69%-$4,412,310+2-7-13
D
2017-04-10
INCYSiegel Eric H.EVP, GCM - OptEx$39.13+4,04316,785+32%+$158,206+2-7-13
D
2017-04-10
INCYSiegel Eric H.EVP, GCS - Sale+OE$140.18-4,04316,785-19%-$566,748+2-7-13
D
2017-04-10
INCYGryska David WEVP, CFOM - OptEx$67.06+41,52819,015-184%+$2,784,868+2-7-13
D
2017-04-10
INCYGryska David WEVP, CFOS - Sale+OE$138.00-41,52819,015-69%-$5,730,864+2-7-13
2017-04-07
INCYBienaime Jean JacquesDirP - Purchase$139.48+1,0002,177+85%+$139,480+2-7-13
2017-03-31
INCYBaker Bros. Advisors LPDir, 10%A - Grant$133.67+426920,3280%+$56,943-2-3-13
2017-03-31
INCYDixon Wendy LDirA - Grant$133.67+1218,833+1%+$16,174+4+1-7
2017-03-31
INCYBrooke Paul ADirA - Grant$133.67+177196,9330%+$23,660+4+1-7
2017-03-31
INCYBienaime Jean JacquesDirA - Grant$133.67+1081,177+10%+$14,436+4+1-7
D
2017-03-17
INCYBrooke Paul ADirM - OptEx$7.26+20,000196,756+11%+$145,200-5-6-15
D
2017-03-17
INCYBrooke Paul ADirS - Sale+OE$147.75-20,000196,756-9%-$2,955,000-5-6-15
DM
2017-03-16
INCYFriedman Paul ADirM - OptEx$18.32+50,000297,518+20%+$916,000-5-6-15
DM
2017-03-16
INCYFriedman Paul ADirS - Sale+OE$148.72-50,000297,518-14%-$7,436,164-5-6-15
2017-02-27
INCYHuber Reid MEVP, Chief Scientific OfficerS - Sale$131.88-2,00852,262-4%-$264,81500+5
D
2017-02-23
INCYFriedman Paul ADirM - OptEx$18.32+50,000297,518+20%+$916,000-1+2+4
D
2017-02-23
INCYFriedman Paul ADirS - Sale+OE$120.32-50,000297,518-14%-$6,016,000-1+2+4
D
2017-02-17
INCYBaker JulianDir, 10%A - Grant$0.00+10,610,782920,186-109%+$00+10+16
2017-01-09
INCYHuber Reid MEVP, Chief Scientific OfficerS - Sale$113.55-11,73952,185-18%-$1,332,963+20+6
2016-12-30
INCYBaker JulianDir, 10%A - Grant$100.27+567687,0000%+$56,853+2+16+18
2016-12-30
INCYDixon Wendy LDirA - Grant$100.27+1628,712+2%+$16,244+2+8+21
2016-12-30
INCYBrooke Paul ADirA - Grant$100.27+236196,7560%+$23,664+2+8+21
2016-12-30
INCYBienaime Jean JacquesDirA - Grant$100.27+1441,069+16%+$14,439+2+8+21

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top